SKI Market

Indian Indices

Nifty

26,033.75 47.75
(0.18%)

Sensex

85,747.83 482.51
( 0.57%)

Bank Nifty

59,288.70 -59.55
( -0.10%)

Nifty IT

38,360.25 535.00
( 1.41%)

Global Indices

Nasdaq

47,874.44 -29.46
(-0.06%)

Dow Jones

6,878.17 7.45
(0.11%)

Hang Seng

50,935.81 1,071.13
(2.15%)

Nikkei 225

9,722.32 30.25
(0.31%)

Forex

USD-INR

90.13 0.27
(0.30%)

EUR-INR

105.04 0.70
(0.67%)

GBP-INR

119.76 1.10
(0.93%)

JPY-INR

0.58 0.00
(0.57%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vikas Lifecare Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

542655

INE161L01027

2.9324378

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIKASLIFE

339.95

EPS(TTM)

Face Value()

Div & Yield %

Back

Zydus Lifesciences receives EIR for facility at Jarod, Vadodara

Dec 04,2025

Zydus Lifesciences has received the Establishment Inspection Report (EIR) from the USFDA for a GMP follow-up inspection conducted at its injectable facility located at Jarod, Vadodara from 25 August to 05 September 2025 and classifying the facility as Voluntary Action Indicated (VAI). This inspection was conducted following the Warning Letter issued on 29 August 2024 by the USFDA.

26,033.75 47.75 (0.18%)

85,747.83 482.51 ( 0.57%)

59,288.70 -59.55 ( -0.10%)

38,360.25 535.00 ( 1.41%)

47,874.44 -29.46 (-0.06%)

6,878.17 7.45 (0.11%)

50,935.81 1,071.13 (2.15%)

9,722.32 30.25 (0.31%)

90.13 0.27 (0.30%)

105.04 0.70 (0.67%)

119.76 1.10 (0.93%)

0.58 0.00 (0.57%)